MONEY

Nxera Pharma GAAP EPS of ¥15.86, revenue of ¥18.91B; reaffirms FY 2026 outlook

ByFinance Desk

Aug 7, 2026 , , , , , , , , ,

Nxera Pharma GAAP EPS of ¥15.86, revenue of ¥18.91B; reaffirms FY 2026 outlook

Source link

By Finance Desk

Related Post

MONEY

MDA Space Non-GAAP EPS of $0.36 beats by $0.10, revenue of $498.6M beats by $180.04M

Aug 7, 2026 Finance Desk
MONEY

Kawasaki Heavy Industries reports Q1 results; raises FY 2026 outlook

Aug 7, 2026 Finance Desk
MONEY

Karman signals $730M-$745M 2026 revenue outlook while targeting 20%-25% annual organic growth (NYSE:KRMN)

Aug 7, 2026 Finance Desk

Leave a Reply

You missed

NEWS TODAY

Several killed after student opens fire inside Thailand school | Crime News

Aug 7, 2026 News Desk
SHOW BIZ

Millie Mackintosh breaks down in tears and sobs as she moves into rental home after shock marriage split with Hugo

Aug 7, 2026 News Desk
MONEY

MDA Space Non-GAAP EPS of $0.36 beats by $0.10, revenue of $498.6M beats by $180.04M

Aug 7, 2026 Finance Desk
SPORT

PERFECT FIT – Los Angeles Times

Aug 7, 2026 Sports Desk

Discover more from Occasional Digest

Subscribe now to keep reading and get access to the full archive.

Continue reading